drugset / Trial / NCT00129272

Effectiveness of Bupropion for Treating Nicotine Dependence in Young People

NCT00129272

Phase 2 Completed 172 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Little is known about the best ways to help young people stop smoking. Bupropion (a medication marketed as Wellbutrin or Zyban) has proved helpful in treating adult smokers. The purpose of this study is to determine if bupropion is also effective in treating smokers between the ages of 12 and 25 years old. This study also compares the effectiveness of bupropion used as a supplement to behavioral treatment versus behavioral treatment used alone. In addition, the study evaluates whether hormonal response to stress measured prior to the start of treatment predicts whether individuals respond well to treatment with medication.

Timeline

Start
2004-05
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupropion Small molecule 150 mg Oral

Indications